| Chemical Structure | ![]() |
| Drug Class | Atypical phenylalkylamine / Dopaminergic |
| Mechanisms of action |
SERT robust inhibition / release DAT inhibition / release Low NET activity Weak TAAR1 interaction possible |
| Monograph |
Chemical Name: 1-(4-phenylphenyl)-N-methylpropan-2-amine Biphenylamphetamine BPMA Development: First synthesized in the 40s. Structural Interest: Biphenyl substitution increases steric bulk and rigidity. BPMA is probably more fat-soluble due to the lipophilic amine, making it easier to pass the blood-brain barrier-and presenting a faster onset and shorter action. Modern Interest:The compound is being evaluated for its potential role in dry stimulation - enhanced wakefulness and performance without classic amphetamine euphoria. Non-euphoric dopaminergics in cognitive and motivational settings. Anorexiant stimulant. |
| Synthesis batch initiated | 1 gram target |Amount acquired for synthesis purposes: 10 g |Amount acquired for speculative holding: 5 g Note: These figures reflect total documented acquisitions. Updated manually |
| OrderBook |
Offer
Bid
|
| Order via | (ONLY TO EUROPE, EXCEPT UK, DENMARK, GERMANY AND AUSTRIA.) |